| |
| |
|
| Insider
Information: |
Waeger Ruedi E |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
24,054 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,389,855 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
24,054 |
|
|
| Total
Value |
$4,389,855 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2010-05-03 |
24,054 |
2006-01-09 |
0 |
Premium* |
|
|
Talecris Biotherapeutics Holding... |
TLCR |
Director |
2011-06-01 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TLCR |
Talecris Biotherapeutics ... |
Director |
– • – |
2011-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(63,587) |
0 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2010-05-03 |
4 |
B |
$55.10 |
$165,314 |
D/D |
3,000 |
24,054 |
2.39 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Director |
– • – |
2010-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,019 |
63,587 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2010-01-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,965 |
21,054 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Director |
– • – |
2009-09-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
60,568 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2009-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,089 |
17,089 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2008-07-31 |
4 |
S |
$93.63 |
$1,825,785 |
D/D |
(19,500) |
6,000 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2008-07-31 |
4 |
OE |
$19.73 |
$394,455 |
D/D |
19,500 |
25,500 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2008-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
6,000 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2007-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
4,000 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
officerTitle |
– • – |
2006-01-09 |
4 |
A |
$20.72 |
$41,440 |
D/D |
2,000 |
2,000 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
